Last week, Neuro-Bio’s RNA-based therapies team met with Professor Lorna Harries at the University of Exeter to discuss project progress and plan future experiments. The meeting was highly productive, sparking new ideas and strengthening the collaboration between...
For those yet to see it, the space is looking fantastic! Attending these events is really important to us – they give us the opportunity to support the community, share ideas, and connect with colleagues across Culham Campus, as well as to share what we are...
Adam has returned to Neuro-Bio as a Senior Scientist, after completing his MSc in Pharmacology at the University of Oxford. Since Adam was last at Neuro-Bio, he has performed radiotracer assays investigating drug interactions at the Blood-brain barrier. He has also...
We were thrilled and thankful to have seen our Office Manager, Charles Monro, attending the Quarterly Tenant Lunch at Culham Campus last week. These events are all about sharing ideas, sparking collaborations, and strengthening the community. We are always keen to...
We are excited to announce a new member and Senior Scientist joining Neuro-Bio Amy Lewis. Amy recently completed her master’s degree at the University of Cambridge, where she worked at the MRC Toxicology Unit, researching drug-induced mitochondrial toxicity....
We are pleased to share a fantastic article by SelectScience® Baroness Susan Greenfield CBE, neuroscientist and founder of Neuro-Bio, has spent four decades developing a novel hypothesis on the origins of Alzheimer’s disease. Now, in collaboration with Aptamer Group,...
